NEUROONE MEDICAL TECHNOLOGIES Corp: Form 10-Q for the period ended Mar 31, 2017
Filed with the SEC on May 22, 2017 and accepted by EDGAR at May 22, 2017, 20:30 ET.
Management's discussion and analysis
As filed, 11,271 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Forward-looking Statements
Statements in this Management’s Discussion and Analysis of Financial Condition and Results of Operation, as well as in certain other parts of this quarterly report on Form 10-Q (as well as information included in oral statements or other written statements made or to be made by Original Source) that look forward in time, are forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, expectations, predictions, and assumptions and other statements which are other than statements of historical facts. Although Original Source believes such forward-looking statements are reasonable, it can give no assurance that any forward-looking statements will prove to be correct. Such forward-looking statements are subject to, and are qualified by, known and unknown risks, uncertainties and other factors that could cause actual results, performance or achievements to differ materially from those expressed or implied by those statements. These risks, uncertainties and other factors include, but are not limited to Original Source’s ability to estimate the impact of competition and of industry consolidation and risks, uncertainties and other factors set forth in Original Source’s filings with the Securities and Exchange Commission, including without limitation to this Quarterly Report on Form 10-Q.
Original Source undertakes no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this Form 10-Q.
General
We were incorporated under the laws of the State of Nevada on August 20, 2009. Our business from inception through to May 13, 2016 was to license songs to the television and music industry for use for use in television shows or movies. We have had limited activity and revenue to date. As of May 13, 2016, we spun-off Original Source Music, our wholly-owned subsidiary which holds all of our operations, to shareholders of record as of February 25, 2014. The spin-off was done in connection with a change of control of our company. Under the terms of the spin-off, Original Source Music’s common shares, par value $0.001 per share, were distributed on a pro-rata basis to each holder of our common shares on the record date without any consideration or action on the part of such holders, and the holders of our common shares as of the record date became owners of 100% of Original Source Music’s common shares, subject to applicable FINRA filings. Accordingly, we are a blank check registrant as that term is defined in Rule 419(a)(2) of Regulation C of the Securities Act of 1933, because we have no specific business plan and purpose.
We currently have no employees other than our sole officer, who is also our sole director.
We do not have any definitive plans, proposals, arrangements or understandings with any representatives of the owners of any operating business or company regarding the possibility of an acquisition or merger. However, we are currently in negotiations with NeuroOne, Inc., a Delaware corporation (“NeuroOne”), with respect to a potential reorganization pursuant to which, as currently contemplated, we would acquire NeuroOne as our wholly-owned subsidiary and the stockholders of NeuroOne would exchange all of the issued and outstanding shares of common stock of NeuroOne currently held by them for shares of the Company’s Common Stock (the “Proposed Transaction”). As the definitive agreement and other transaction documents are still being negotiated, and the parties are still performing due diligence, we can give no assurance as to the ultimate form or terms of the Proposed Transaction or that the Proposed Transaction will be consummated at all.
Recent Events
Our Board of Directors and majority stockholder, who is also our Chief Executive Officer and sole director, authorized, on April 17, 2017:
- An amendment to our Articles of Incorporation to effect a change of our name from “Original Source Entertainment, Inc.” to “NeuroOne Medical Technologies Corporation.”
- An amendment to our Articles of Incorporation to effect an increase in the number of authorized shares of our common stock from 45,000,000 to 100,000,000 and to increase the number of authorized shares of our preferred stock from 5,000,000 to 10,000,000.
- A Certificate of Amendment to our Articles of Incorporation, which makes no material changes to our existing Articles of Incorporation other than incorporating the amendments described in the prior bullets.
- A change to our state of incorporation from the State of Nevada to the State of Delaware pursuant to a plan of conversion in connection with which the Company will adopt a new certificate of incorporation and bylaws under the laws of the State of Delaware.
- The adoption of a 2017 Equity Incentive Plan.
We are not required to effect any of the above first three corporate actions, and may determine to do so only if and when the Proposed Transaction is consummated, of which we can give no assurance of success.
Critical Accounting Policies
The following discussion as well as disclosures included elsewhere in this Form 10-Q are based upon our unaudited financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. These financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America.
The preparation of these financial statements requires management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures of contingencies. Original Source continually evaluates the accounting policies and estimates used to prepare the financial statements. Original Source bases its estimates on historical experiences and assumptions believed to be reasonable under current facts and circumstances. Actual amounts and results could differ from these estimates made by management.
Trends and Uncertainties
There are no material commitments for capital expenditure at this time. There are no trends, events or uncertainties that have had or are reasonably expected to have a material impact on our limited operations. There are no known causes for any material changes from period to period in one or more line items of Original Source’s financial statements.
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As shown in the accompanying financial statements, we have incurred losses of $8,754 and $8,959 for the three months ended March 31, 2017 and 2016, respectively, and have a working capital deficiency which raises substantial doubt about our ability to continue as a going concern.
Management believes the Company will continue to incur losses and negative cash flows from operating activities for the foreseeable future and will need additional equity or debt financing to sustain its operations.
Management plans to seek additional debt and/or equity financing for the Company, but cannot assure that such financing will be available on acceptable terms.
The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Results of Operations
During the three months ended March 31, 2017, we earned revenues of $0. We had general and administrative expenses of $8,754. As a result, we had a net loss of $8,754 for the three months ended March 31, 2017.
By comparison, during the three months ended March 31, 2016, we earned revenues of $0. We paid general and administrative expenses of $4,386 and had a loss from discontinued operations of $4,573. As a result, we had a net loss of $8,959 for the three months ended March 31, 2016.
The $205 decrease in net loss for the three months ended March 31, 2017 compared to the three months ended March 31, 2016 is primarily the result of the decrease in loss from discontinued operations of $4,573 offset by an increase in general and administrative expenses of $4,368 primarily from professional fees, which consist of fees paid for legal, accounting, and auditing services, were incurred primarily to enable us to satisfy the requirements of a reporting company.
Liquidity and Capital Resources
At March 31, 2017, and December 31, 2016 we had a cash balance of $0.
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As shown in the accompanying financial statements, Original Source has incurred losses of $8,754 and $8,959 for the three months ended March 31, 2017 and 2016, respectively, and a working capital deficiency which raises substantial doubt about the Company’s ability to continue as a going concern.
Management believes the Company will continue to incur losses and negative cash flows from operating activities for the foreseeable future, including as a result of the spin-off of our operating business as of May 13, 2016, and will need additional equity or debt financing to sustain its operations. Management plans to seek additional debt and/or equity financing for the Company, but cannot assure that such financing will be available on acceptable terms.
The Company’s continuation as a going concern is dependent upon its ability to ultimately attain profitable operations, generate sufficient cash flow to meet its obligations, and obtain additional financing as may be required. Our auditors have included a “going concern” qualification in their auditors’ report dated April 17, 2017. Such a “going concern” qualification may make it more difficult for us to raise funds when needed. The outcome of this uncertainty cannot be assured.
The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Operating Activities
During the three months ended March 31, 2017, we used $3,288 in operating activities compared to $0 during the three months ended March 31, 2016.
During the three months ended March 31, 2017 we incurred a loss of $8,754 which was partially offset for cash flow purposes as we reduced our balance of accounts payable and accrued liabilities by $5,466. By comparison, during the three months ended March 31, 2016, we incurred losses of $8,959 which was partially offset for cash flow purposes by $4,015 in non-cash expenses and we decreased our balance of accounts payable and accrued liabilities by $ 4,686.
Investing Activities
During the three month periods ended March 31, 2017 and 2016, we did not pursue any investing activities.
Financing Activities
During the three months ended March 31, 2017, we received $3,288 by way of advances – related party. By comparison, we received $0 from advances – related party during the three months ended March 31, 2016.
Recently Issued Accounting Standards
Management does not believe that any other recently issued, but not yet effective, accounting standard if currently adopted would have a material effect on the accompanying financial statements.
Off Balance Sheet Arrangements
None.
Controls and procedures
As filed, 1,499 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
During the three months ended March 31, 2017, there were no changes in our internal controls over financial reporting (as defined in Rule 13a- 15(f) and 15d-15(f) under the Exchange Act) that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Evaluation of Disclosure Controls and Procedures
Under the supervision and with the participation of our management, including our chief executive officer and principal financial officer, we conducted an evaluation of our disclosure controls and procedures, as such term is defined under Rule 13a-15(e) and Rule 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended, as of March 31, 2017. Based on this evaluation, our chief executive officer and principal financial officer have concluded such controls and procedures to be ineffective as of March 31, 2017 to ensure that information required to be disclosed by the issuer in the reports that it files or submits under the Act is recorded, processed, summarized and reported, within the time periods specified in the Commission's rules and forms and to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Act is accumulated and communicated to the issuer's management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2017-01-01 to 2017-03-31 | $0 | us-gaap:SalesRevenueNet |
| Operating income | 3 months2017-01-01 to 2017-03-31 | −$8.8k | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2017-01-01 to 2017-03-31 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2017-01-01 to 2017-03-31 | −$8.8k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2017-01-01 to 2017-03-31 | $0.00 | us-gaap:EarningsPerShareBasicAndDiluted |
| Total assets | At period end2017-03-31 | $0 | us-gaap:Assets |
| Current liabilities | At period end2017-03-31 | $104.9k | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2017-03-31 | $104.9k | us-gaap:Liabilities |
| Shareholders' equity | At period end2017-03-31 | −$104.9k | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001144204-17-028884. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.